Part,  Chapter, Paragraph

1   II,     5.  5.  3|        therapies (Eichhorn and Oertel, 1994). In the pre-levodopa
2   II,     5.  5.  3|   Szucs T, Rathay B, Scholz E, Oertel WH (1998): The economic
3   II,     5.  5.  3|        9):693-721.~Eichhorn T, Oertel WH (1994): Incidence, differential
4   II,     5.  5.  3| Kanovsky P, Larsen JP, Lees A, Oertel W, Poewe W, Rascol O, Sampaio
5   II,     5.  5.  3|    Forstl H, Henn F, Heuser I, Oertel W, Reichmann H, Riederer
6   II,     5.  5.  3|    Brandstaedter D, Siebert U, Oertel WH, Ulm G, Dodel R (2005):
7   II,     5.  5.  3|  Botzel K, Sampaio C, Poewe W, Oertel W, Siebert U, Berger K,